What is the price target for PRTA stock?
12 analysts have analysed PRTA and the average price target is 21.42 USD. This implies a price increase of 100.75% is expected in the next year compared to the current price of 10.67.
PROTHENA CORP PLC (PRTA) Forecast, Price Target & Analyst Ratings
NASDAQ:PRTA • IE00B91XRN20
Current stock price
10.67 USD
-0.12 (-1.11%)
At close:
10.67 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROTHENA CORP PLC (PRTA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.36
- Revenue Estimate
- 824.16K
Price Target Details & History
Consensus Price Target and Range
Mean target
$21.42
Upside
+ 100.75%
From current price of $10.67 to mean target of $21.42, Based on 12 analyst forecasts
Low
$8.08
Median
$19.38
High
$37.80
Price Target Revisions
1 Month
2.44%
3 Months
3.28%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for PRTA. The average price target is 21.42 USD. This implies a price increase of 100.75% is expected in the next year compared to the current price of 10.67.
The average price target has been revised upward by 3.28% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.00%
PRTA was analyzed by 12 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about PRTA.
In the previous month the buy percentage consensus was at a similar level.
PRTA was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-12-01 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-02 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-08-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-20 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-05-28 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-05-27 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-27 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-27 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2025-05-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-21 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.36
- Revenue Estimate
- 824.16K
- Revenue Q2Q
- -70.86%
- EPS Q2Q
- 68.28%
- Number of Analysts
- 8
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-5.55%
Next Earnings Summary
PRTA is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.36 USD and the consensus revenue estimate is 824.16K USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 91.37M 69.52% | 135.157M 47.92% | 9.684M -92.83% | 117.31M 1,111.38% | 26.928M -77.05% | 103.1M 282.87% | 102.27M -0.81% | 270.91M 164.90% | 288.91M 6.64% | 381.84M 32.17% | 446.84M 17.02% | |
| EBITDA YoY % growth | -190.108M -45.28% | -153.668M 19.17% | -183.665M -19.52% | 100.00% | N/A | N/A | N/A | N/A | N/A | N/A | ||
| EBIT YoY % growth | -191.036M -45.16% | -154.561M 19.09% | -184.56M -19.41% | 39.273M 121.28% | -45.547M -215.98% | 13.594M 129.85% | 1.042M -92.33% | 137.53M 13,098.66% | 154.31M 12.20% | 237.75M 54.07% | 299.45M 25.95% | |
| Operating Margin | -209.08% | -114.36% | -1,905.82% | 33.48% | -169.14% | 13.19% | 1.02% | 50.77% | 53.41% | 62.26% | 67.02% | |
| EPS YoY % growth | -2.80 -11.55% | -2.30 17.86% | -3.93 -70.87% | 0.26 106.59% | -1.03 -499.61% | 0.39 137.96% | -1.24 -416.88% | 3.45 377.05% | 1.51 -56.21% | 2.50 65.88% | 2.73 8.96% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 68.28% | 0.33 118.97% | 0.10 114.25% | 0.14 136.13% | -0.27 25.36% | -0.26 -177.72% | -0.24 -352.63% | -0.24 -269.41% |
| Revenue Q2Q % growth | 824.16K -70.86% | 43.957M 894.50% | 26.073M 979.63% | 31.533M 150,057.14% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.621M 70.08% | 25.807M 149.62% | 18.895M 147.52% | 9.595M 135.26% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
28.06%
EPS Next 5 Year
23.54%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
109.06%
Revenue Next 5 Year
88.83%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PROTHENA CORP PLC / PRTA Forecast FAQ
What is the next earnings date for PRTA stock?
PROTHENA CORP PLC (PRTA) will report earnings on 2026-05-13.
What are the consensus estimates for PROTHENA CORP PLC (PRTA) next earnings?
The consensus EPS estimate for the next earnings of PROTHENA CORP PLC (PRTA) is -0.36 USD and the consensus revenue estimate is 824.16K USD.
Can you provide the expected long term growth rate for PROTHENA CORP PLC stock?
The expected long term growth rate for PROTHENA CORP PLC (PRTA) is 109.06%.